Syndax Pharmaceuticals Inc
F:1T3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Syndax Pharmaceuticals Inc
F:1T3
|
US |
|
U
|
United Brands Ltd
KAR:UBDL
|
PK |
|
H
|
Hokuetsu Metal Co Ltd
TSE:5446
|
JP |
|
Environmental Clean Technologies Ltd
ASX:ECT
|
AU |
|
A
|
Admiralty Resources NL
SWB:AHS
|
AU |
|
FBR Ltd
ASX:FBRDD
|
AU |
|
Saudi Printing and Packaging Company SJSC
SAU:4270
|
SA |
|
C
|
Carnegie Clean Energy Ltd
F:CNM1
|
AU |
|
Bachem Holding AG
F:BHM
|
CH |
|
Parrot SA
F:P2W
|
FR |
|
C
|
Conn's Inc
F:CN4
|
US |
|
M
|
Morarjee Textiles Ltd
BSE:532621
|
IN |
|
A
|
Aspermont Ltd
F:00W
|
AU |
|
Jammin Java Corp
OTC:JAMN
|
US |
|
S
|
Stabilus SE
DUS:STM
|
DE |
|
P
|
PTC India Financial Services Ltd
BSE:533344
|
IN |
|
I
|
Indofood Agri Resources Ltd
OTC:INDFY
|
SG |
|
Sodexo SA
F:SJ7
|
FR |
|
R
|
Renegade Gold Inc
F:070
|
CA |
|
Edreams Odigeo SA
F:1ED
|
ES |
Bankruptcy Probability
Syndax Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Syndax Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
1.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
470B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Syndax Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Syndax Pharmaceuticals Inc has total debt of 588.1m USD. This includes both short-term (0 USD) and long-term (588.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
